Cencora, Inc. (COR) Expands into Retina Services Business in $1.1 Billion Deal
Cencora, Inc. (NYSE:COR) is one of the stocks positioned for great growth. On March 24, UBS reiterated a Buy rating on Cencora, Inc. (NYSE:COR) with a price target of $410. The bullish stance is in response to the company’s announcement of its $1.1 billion acquisition of partner EyeSouth’s retina business. Cencora, Inc. (COR) Expands into…